MoneyWorks4Me

Divis Laboratories informs about outcome of board meeting

01 Aug 2026 Evaluate
Further to letter dated July 20, 2026, Divis Laboratories has informed that the Board of Directors of the Company at its meeting held on August 01, 2026, has approved the unaudited financial results for the quarter ended June 30, 2026; Appointment of Senior Management Personnel Approved appointment of B. Vara Prasad, General Manager (Engineering Purchase) and J. Srinivasa Rao, General Manager (Raw Materials Purchase) as Senior Management Personnel of the Company as recommended by the Nomination and Remuneration Committee, with effect from August 01, 2026.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..